5 Dow Jones Stocks Every Investor Should Own

5. Pfizer Inc. (NYSE:PFE)

On the fifth spot we have Pfizer Inc. (NYSE:PFE), in which 72 funds from our database held long positions at the end of the first quarter, down by ten over the quarter. Pfizer registered a significant decline in popularity last year, as there were 119 funds long the stock at the end of March 2016. However, Pfizer’s cancelled merger with Allergan plc (NYSE:AGN) took most of the catalysts that investors had been looking for off the table. Pfizer Inc. (NYSE:PFE)’s stock has gained over 4% since the beginning of the year and it currently sports a dividend yield of 3.80%.

For the last two quarters, Pfizer has reported year-over-year declines in revenue, which was also lower than expected in both cases. The declines in sales were particularly notable because Pfizer Inc. (NYSE:PFE) is about to lose the exclusivity on two of its best-selling drugs, Viagra (this year) and Lyrica (next year). However, Pfizer is trying to develop new products and has a bunch of promising drugs in Phase III studies, including drugs for non-small cell lung cancer. In addition, the high dividend yield and attractive valuation at 13-times forward earnings makes Pfizer Inc. (NYSE:PFE) a worthy portfolio addition.

pio3 / Shutterstock.com